SEC Form 4 · accession 0001493152-17-014733
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Isaac Simtob
Director
Period of report
Dec 15, 2017
Accepted (ET)
Dec 18, 2017 · 7:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 15, 2017 | P | 100 | $3.90 | A | 46,536 | D | |
| Common Stock | Dec 18, 2017 | P | 5,552 | $4.00 | A | 52,088 | D | |
| Common StockF1 | holding | — | — | — | 155 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Owned by minor child.